Psychiatric medications: Adverse cutaneous drug reactions

被引:33
|
作者
Bliss, Sarah A. [1 ]
Warnock, Julia K. [1 ]
机构
[1] Univ Oklahoma, Dept Psychiat, Hlth Sci Ctr, Tulsa, OK 74135 USA
关键词
TOXIC EPIDERMAL NECROLYSIS; CARBAMAZEPINE HYPERSENSITIVITY SYNDROME; HAIR LOSS; SKIN PIGMENTATION; LAMOTRIGINE; PHOTOSENSITIVITY; FLUOXETINE; ERUPTION; IMIPRAMINE; ALOPECIA;
D O I
10.1016/j.clindermatol.2011.11.014
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Psychiatric medications are among the most widely prescribed medications in the United States. Adverse cutaneous drug reactions are associated with psychiatric medications in approximately 2% to 5% of the individuals for whom they are prescribed. Although most adverse cutaneous drug reactions associated with psychotropic medications are benign and easily treated, some can be disfiguring or life-threatening, particularly those associated with the mood stabilizers. Adverse cutaneous drug reactions associated with antidepressants, antipsychotics, and mood stabilizers are reviewed, and important issues that are of concern for the dermatologist who must consider when and how to safely discontinue a psychotropic medication in their patients are presented. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [21] ADVERSE CUTANEOUS DRUG-REACTIONS
    BORK, K
    MEDIZINISCHE WELT, 1987, 38 (09): : 254 - 255
  • [22] Severe Cutaneous Adverse Drug Reactions
    Schroeder, J.
    DRUG SAFETY, 2013, 36 (09) : 942 - 942
  • [23] Cutaneous adverse drug reactions to cetirizine
    Klos, K.
    Kruszewski, J.
    Chcialowski, A.
    Slaweta, G.
    ALLERGY, 2010, 65 : 254 - 254
  • [24] Adverse Cutaneous Reactions of Common Biologic Medications for Rheumatic Diseases
    Khanna, Urmi
    Ellis, Ariana M.
    Fernandez, Anthony P.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (04) : 290 - 312
  • [25] Adverse Cutaneous Reactions of Common Biologic Medications for Rheumatic Diseases
    Urmi Khanna
    Ariana M. Ellis
    Anthony P. Fernandez
    Current Treatment Options in Rheumatology, 2019, 5 : 290 - 312
  • [26] Utilization of hospital and outpatient care for adverse cutaneous reactions to medications
    Stern, RS
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (10) : 677 - 684
  • [27] Adverse Drug Reactions Induced by Multiple Sclerosis Medications
    Abolfazli, R.
    Kh, Gholami
    Salehbayat, M.
    Mohebbi, N.
    Javadi, M. R.
    Heidari, K.
    Shalviri, G.
    Samadzadeh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 339 - 339
  • [28] Psychiatric adverse drug reactions in the paediatric population
    Ekhart, Corine
    de Vries, Tjalling
    van Hunsel, Florence
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (08) : 749 - 755
  • [29] ADVERSE CUTANEOUS DRUG-REACTIONS IN AIDS
    DERAEVE, L
    SONG, M
    VANMALDERGEM, L
    BRITISH JOURNAL OF DERMATOLOGY, 1988, 119 (04) : 521 - 523
  • [30] Treatment of severe cutaneous adverse drug reactions
    Ingen-Housz-Oro, S.
    Duong, T-A
    de Prost, N.
    Colin, A.
    Fardet, L.
    Lebrun-Vignes, B.
    Barbaud, A.
    Chosidow, O.
    Wolkenstein, P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2018, 145 (6-7): : 454 - 464